About The Summit
This summit is an unparalleled event for the cell therapy field, serving as a pivotal hub that brings together technical leaders – process development, technical operations, CMC, MSAT, and more – with the aim to streamline end-to-end process development and manufacture effective, safe, and consistent autologous and allogeneic cell therapy products.
Enforce an effective control strategy during early development, incorporating Quality by Design principles, to guarantee a robust and consistently successful process with Quell Therapeutics & Lyell Immunopharma
Optimize the quality of cellular starting material seamlessly and reconcile the transition from health donor to patient material with precision, to ensure a reliable downstream process with Century Therapeutics & Immatics
Introduce post-IND process enhancements with finesse, showcasing comparability successfully and elevating the performance and quality of the final product with 2seventy bio & ArsenalBio
Advance towards increasingly automated and closed manufacturing processes to reduce manual intervention, improve product quality, and reduce costs with Beam Therapeutics & Imugene
Enhance process scale-out and scale-up to facilitate the manufacture of autologous and allogeneic cell therapies at both clinical and commercial scale with Be Biopharma & ImmuneBridge
Conquer downstream processing challenges comprehensively, addressing all facets of fill-finish including visual inspection and cryopreservation, to maximize product safety and efficacy with Caribou Biosciences & Tr1X
